#GenderAffirmingHormoneTherapy and Health Information on TikTok: Thematic Content Analysis
JMIR Infodemiology · 2025
DOI: 10.2196/66845 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Infodemiology, 2025. Verfasst von Julia Rose Beatini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Jefferson University, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Social Media, Transgender Persons, Gender-Affirming Procedures, Patient Education as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transgender and gender diverse people often turn to online platforms for information and support regarding gender-affirming hormone therapy (GAHT); however, analysis of this social media content remains scarce.
Objective
We characterized GAHT-related videos on TikTok to highlight the implications relevant to GAHT prescribers.
Methods
We used a web scraper to identify TikTok videos posted under the hashtags #genderaffirminghormonetherapy and #genderaffirminghormones as of November 2023. We identified recurrent themes via qualitative content analysis and assessed health education videos with the Patient Education Materials Assessment Tool for Audiovisual Materials (PEMAT-A/V) scale and a modified Currency, Relevance, Authority, Accuracy, and Purpose (CRAAP) test.
Results
Out of 69 videos extracted, 71% (49/69) were created by GAHT users, 24.6% (17/69) were created by health care workers, and 21.7% (15/69) were created to provide health education. Themes included physical changes on testosterone, GAHT access, and combating misinformation and stigma surrounding GAHT. Health education videos scored highly on PEMAT-A/V items assessing understandability (mean 88.3%, SD 11.3%) and lower on actionability (mean 60.0%, SD 45.8%). On the CRAAP test, videos scored highly on the relevance, authority, and purpose domains but lower on the currency and accuracy domains.
Conclusions
Discussions of GAHT on TikTok build community among transgender and gender diverse users, provide a platform for digital activism and resistance against legislation that limits GAHT access, and foster patient-provider dialogue. Educational videos are highly understandable and are created by reliable sources, but they vary in terms of currency and quality of supporting evidence, and they lack in actionability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thomas Jefferson University, Philadelphia, PA, United States.
- Harvard University, Cambridge, MA, United States.
- Harvard Medical School, Boston, MA, United States.
- Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, United States.
- Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Wang Building 8th Floor, Boston, MA, 02114, United States, 1 (857) 313-6688, 1 (617) 267-0764.
- The National LGBTQIA+ Health Education Center, The Fenway Institute, Boston, MA, United States.
ORCID-Profile: Julia Rose Beatini, Nora Yanyi Sun, Julianna K Coleman, Maetal E Haas-Kogan, Andrea Pelletier, Deborah Bartz, Alex Sogomon Keuroghlian
Zitieren
APA
Beatini, J. R., Sun, N. Y., Coleman, J. K., Haas-Kogan, M. E., Pelletier, A., Bartz, D., & Keuroghlian, A. S. (2025). #GenderAffirmingHormoneTherapy and Health Information on TikTok: Thematic Content Analysis. JMIR Infodemiology. https://doi.org/10.2196/66845
Vancouver
Beatini JR, Sun NY, Coleman JK, Haas-Kogan ME, Pelletier A, Bartz D, et al. #GenderAffirmingHormoneTherapy and Health Information on TikTok: Thematic Content Analysis. JMIR Infodemiology. 2025. doi:10.2196/66845
BibTeX
@article{Beatini2025,
author = {Beatini, Julia Rose and Sun, Nora Yanyi and Coleman, Julianna K and Haas-Kogan, Maetal E and Pelletier, Andrea and Bartz, Deborah and Keuroghlian, Alex Sogomon},
title = {#GenderAffirmingHormoneTherapy and Health Information on TikTok: Thematic Content Analysis},
journal = {JMIR Infodemiology},
year = {2025},
doi = {10.2196/66845}
}
EUVIMED